Document Detail

Difluoromethylornithine: the proof is in the polyamines.
MedLine Citation:
PMID:  23221207     Owner:  NLM     Status:  MEDLINE    
In this issue (beginning on page 1368), Kreul and colleagues report a retrospective review of long-term efficacy and toxicity for subjects participating in a phase III study of difluoromethylornithine (DFMO) for prevention of nonmelanoma skin cancer (NMSC). They conclude that those treated with DFMO had a nonsignificant, persistent decrease in NMSC after completion of treatment and that treatment with DFMO did not result in late toxicity after the discontinuation of treatment. We review the data on DFMO as a chemopreventive agent for skin and other cancers, discuss the necessary qualities of a cancer chemopreventive agent, and reflect on the requirements for a well-conducted cancer chemoprevention study, including the rationale for long-term follow-up in cancer prevention studies.
Joanne M Jeter; David S Alberts
Related Documents :
24343987 - Bone-seeking radiopharmaceuticals for treatment of osseous metastases, part 1: α thera...
10161507 - Antiemetic therapy in managed care oncology: roundtable discussion.
2433037 - Mitomycin and mitoxantrone in previously treated patients with advanced breast cancer.
24564607 - The economics of abiraterone acetate for castration-resistant prostate cancer.
15803357 - Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.
18598357 - Monitoring of people and workers exposure to the electric, magnetic and electromagnetic...
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  Cancer prevention research (Philadelphia, Pa.)     Volume:  5     ISSN:  1940-6215     ISO Abbreviation:  Cancer Prev Res (Phila)     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  2013-05-23     Revised Date:  2014-08-05    
Medline Journal Info:
Nlm Unique ID:  101479409     Medline TA:  Cancer Prev Res (Phila)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1341-4     Citation Subset:  IM    
Copyright Information:
©2012 AACR
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Eflornithine / pharmacology*
Skin Neoplasms / prevention & control*
Grant Support
Reg. No./Substance:
Comment On:
Cancer Prev Res (Phila). 2012 Dec;5(12):1368-74   [PMID:  23060038 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The time burden of alcohol-based hand cleanser when using nonsterile gloves.
Next Document:  A novel ROM compression architecture for DDFS utilizing the parabolic approximation of equi-section ...